Sandoz Sets Out Solid Growth In First Standalone Results

Biosimilars Help To Drive 9M Increases; Firm Also Issues CHF750m In Inaugural Bonds

Up arrows on blue background illustration
Sandoz has reported growth as it delivered 9M results • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business